ebomi
Colour theme
Sign in
Insider · CIK 0001595855

Opaleye Management Inc.

CIK 0001595855 Name as filed on the most recent filing

Filed as Opaleye Management Inc. (211)

514 transaction lines · from 211 filings · filed 2015-05-20 to 2026-08-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

514 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-04-24 P, Open-market purchase Harrow, Inc.HROW 84,093, acquired Open Form 4 filing 0001493152-24-015806
2024-04-23 P, Open-market purchase Harrow, Inc.HROW 120,547, acquired Open Form 4 filing 0001493152-24-015806
2024-04-19 P, Open-market purchase Harrow, Inc.HROW 310,391, acquired Open Form 4 filing 0001493152-24-015410
2024-03-28 P, Open-market purchase Harrow, Inc.HROW 641,000, acquired Open Form 4 filing 0001493152-24-011815
2024-03-20 P, Open-market purchase Harrow, Inc.HROW 488,290, acquired Open Form 4 filing 0001493152-24-010936
2023-11-15 P, Open-market purchase Harrow, Inc.HROW 200,735, acquired Open Form 4 filing 0001493152-23-041661
2023-11-10 S, Open-market sale Tracon Pharmaceuticals, Inc.TCON 2 lines 1,401,571, disposed Open Form 4 filing 0001493152-23-041038
2023-09-20 P, Open-market purchase Harrow Health, Inc.HROW 86,710, acquired Open Form 4 filing 0001493152-23-033247
2023-09-19 P, Open-market purchase Harrow Health, Inc.HROW 205,366, acquired Open Form 4 filing 0001493152-23-033247
2023-03-09 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 240,821, acquired Open Form 4 filing 0001493152-23-007400
2022-12-30 S, Open-market sale Protara Therapeutics, Inc.TARA 2 lines 41,949, acquired Open Form 4 filing 0001493152-22-037191
2022-12-14 P, Open-market purchase Harrow Health, Inc.HROW 2 lines 4,536,045, acquired Open Form 4 filing 0001493152-22-035435
2022-12-14 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 2 lines 209,877, acquired Open Form 4 filing 0001493152-22-035779
2022-12-06 S, Open-market sale Tracon Pharmaceuticals, Inc.TCON 2,216, disposed Open Form 4 filing 0001493152-22-034965
2022-11-03 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 158,285, acquired Open Form 4 filing 0001493152-22-030666
2022-10-18 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 2 lines 20,625, acquired Open Form 4 filing 0001493152-22-028929
2022-10-11 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 128,000, acquired Open Form 4 filing 0001493152-22-028176
2022-09-29 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 16,370, acquired Open Form 4 filing 0001493152-22-027414
2022-09-28 P, Open-market purchase Harrow Health, Inc.HROW 2 lines 108,354, acquired Open Form 4 filing 0001493152-22-027192
2022-09-27 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 2,877, acquired Open Form 4 filing 0001493152-22-027085
2022-09-23 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 54,393, acquired Open Form 4 filing 0001493152-22-026798
2022-09-22 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 2 lines 29,943, acquired Open Form 4 filing 0001493152-22-026586
2022-09-20 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 18,524, acquired Open Form 4 filing 0001493152-22-026411
2022-09-19 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 145,584, acquired Open Form 4 filing 0001493152-22-026276
2022-09-19 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 9,367, acquired Open Form 4 filing 0001493152-22-026270
2022-09-16 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 19,173, acquired Open Form 4 filing 0001493152-22-026144
2022-09-15 P, Open-market purchase Protara Therapeutics, Inc.TARA 2 lines 27,740, acquired Open Form 4 filing 0001493152-22-025978
2022-09-15 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 33,680, acquired Open Form 4 filing 0001493152-22-026144
2022-09-14 P, Open-market purchase Protara Therapeutics, Inc.TARA 2 lines 66,068, acquired Open Form 4 filing 0001493152-22-025978
2022-08-16 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 42,285, acquired Open Form 4 filing 0001493152-22-025979
2022-08-16 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 2,520,000, acquired Open Form 4 filing 0001493152-22-023186
2022-08-10 P, Open-market purchase Tela Bio, Inc.TELA 2 lines 102,089, acquired Open Form 4 filing 0001493152-22-022193

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 373
  • Open-market sale 141
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Opaleye Management Inc., insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001595855

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.